Objective. Research has shown that there is an association between Inflammatory Bowel Disease, anxiety and mood disorders, however little is known about their association with Eating Disorders. In this paper we will present a case of a young female with a comorbid diagnosis of Inflammatory Bowel Disease and Eating Disorder, and then discuss the res ults from a systematic review of the literature, describing published cases of patients with the same condition. Methods. A systematized review of the literature was conducted according to MOOSE guidelines. A computerized literature search of MEDLINE, Psyc INFO and EMBASE, and a manual search through reference lists of selected original articles were performed to identify all published case-reports, case series and studies of Inflammatory Bowel Disease and Eating Disorders. Results. Fourteen articles were included, encompassing 219 cases, including ours. The vast majority were females ranging from 10 to 44 years old. Anorexia Nervosa (n=156) and Crohn's Disease (n=129) was the most frequent combination (n=90) reported in the literature. These cases present a poor prognosis because of corticoid refusal, medication abandon and/or deliberate exacerbation of IBD symptoms, in the context of trying to lose weight. Conclusion. Recent evidence suggests there is a possible association between Inflammatory Bowel Disease and Eating Disorders, although the mechanisms involved in its ethiopathogenesis are still unknown. To be aware of this association is important because a delayed diagnosis of this comorbidity may lead to worse prognosis. Further research and a multidisciplinary approach could facilitate earlier diagnosis and provide therapeutic interventions KEY WORDS.
INTRODUCTION
Inflammatory Bowel Disease (IBD) is a group of conditions/disorders characterized by chronic inflammation of the gastrointestinal tract and episodes of relapses and remissions ; especially in genetically susceptible individuals exposed to environmental risk factors 1, 2 . IBD comprises Crohn's Disease (CD), Ulcerative Colitis (UC), microscopic colitis, indeterminate colitis and pouchitis 3 . The prevalence of IBD may be increasing as a result of the low mortality, the earlier diagnoses and the longer duration of disease 1 . The registered prevalence of CD varies from 0.6
to 322 per 100,000 in Europe, and from 4.9 to 505 per 100,000 in case of UC 2 . Most studies showed a peak incidence in the second to fourth decade, with the highest incidence amongst 20
to 29 year old 1, 2 . There are not great differences between males and females 1, 2 .
The association between IBD and some mental disorders, especially anxiety and mood disorders, has been extensively studied [4] [5] [6] . According to the meta-analysis by Neuendorf et al. 6 , the prevalence of anxiety and depressive disorders in IBD is 21% and 15% respectively. These rates increase up to 35% for anxiety symptoms and 22% for depressive symptomatology.
However, other mental disorders have received sparse attention in literature. Especially, and despite the potential overlap in symptoms, the relationship between eating disorders (ED) and IBD has not been widely studied.
Anorexia Nervosa (AN) and Bulimia Nervosa (BN) have been the main diseases classically established as ED 7 . Nevertheless, eating disorder not otherwise specified (EDNOS), which includes partial syndromes of AN and BN, has been the most commonly diagnosed 8 till the recent publication of Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM -5) 9 . The point prevalence of EDNOS in a nation-wide community sample of young females was 2.4% 8 . In the case of AN and BN, the lifetime prevalence amongst women range from 0 to 0.9% and from 0.9 to 1.5% respectively 8 . AN has an overall incidence rate of 4.2-8.1 new cases
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Page 5 of 25 per 100,000 persons per year 10 . In addition, AN presents the highest rate of mortality amongst all psychiatric illnesses, with a Crude Mortality Rate of 5.1 deaths per 1000 person-years 8 .
There are some groups who have studied the role of diet in IBD [11] [12] [13] . It has been reported that patients with IBD have strong beliefs about some food triggering IBD symptoms 11 , which frequently drives them to avoid specific nutrients and/or reduce global intake. This may exacerbate malnutrition, and moreover it also may have an impact on their social life, as it usually involves events that include eating and drinking 11 . Both, malnutrition and social isolation have been related with a significant reduction of quality of life in this population 12 . In addition, there are common features in both ED and IBD (see table 1 ) which may lead to misdiagnosis. It has been reported mainly between IBD and AN [14] [15] [16] [17] [18] [19] [20] [21] due to the restrictive pattern 13 , body mass index (BMI) reduction, predominance of females and similar age of onset 2, 22, 23 . Apart from the overlapping symptomatology, both conditions can also coexist as described in the case below, making differential diagnosis more difficult (see table I ).
Page 6 of 25 There is a paucity of research looking at eating attitudes and behaviours in diet-related chronic health conditions 24 and autoimmune diseases such as IBD 25 . Satherley et al. 13 have recently reported higher prevalence of disordered eating symptoms in participants with IBD relative to healthy controls. Nevertheless, to our knowledge there is no previous review focusing on subjects with IBD fulfilling criteria for a diagnosis of an eating disorder. Thus, we present a case of a young female with a comorbid diagnosis of IBD and ED, and a systematized review of published cases of patients with the same condition. During her admission, she frequently refused to eat due to early satiety, abdominal pain and nausea, despite the gastroenterologist's recommendation of oral intake. In addition, she also hid prescribed medication and did not take it. Since the age of 14 she also reported a selective pattern of eating, progressive restriction of food intake, and feeling more comfortable using enteral nutrition. She did not describe body image disturbance or fear of gaining weight.
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Considering her BMI, the amenorrhea and the restrictive diet she was finally diagnosed with EDNOS.
METHODS
This systematized review was conducted according to the guidelines for Meta-Analyses and Systematic Reviews of Observational Studies (MOOSE) 26 .
A 
RESULTS
The search strategy identified 495 records, after removing 80 duplicates. 461 were excluded at first screening based on titles and abstracts, leaving 34 articles for full text review. Of them, we included 14 articles, excluding 20 articles for the reasons listed in Figure I . Amongst the 14 articles, there were two retrospective cohort studies 27, 28 , six case reports [29] [30] [31] [32] [33] [34] , and six case series 19, [35] [36] [37] [38] [39] (Table II) . 
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A total of 219 patients, including our case, with a comorbid diagnosis of IBD and ED have been reported in the scientific literature (Table II) . The vast majority were females, with only three cases reported on males. The mean ages ranged from 10 to 44. AN (n=156) and CD (n=129)
were the most prevalent diagnosis amongst ED and IBD respectively. In fact, the comorbidity between them, AN plus CD, has been the most frequent combination reported in the literature (n=90) (see figure 2 for more details). The index diagnosis was IBD in 106 out of 211 patients, while ED was the first diagnosis made in 105 out of 211 (See figure II) . There were no data on first diagnosis in 8 patients. ED were clinically diagnosed in case reports and in the two epidemiological studies they did not report any screening instrument (the cohorts were from subjects with ED). 
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Of the seventeen patients described in case reports or case series studies, five of them used the IBD symptomatology to potentiate weight loss (it was suspected in another case but not confirmed) with methods specified in 4 cases: 1) by taking laxatives; 2) by taking products with lactose despite being intolerant to it; 3) by combining both previous methods; and 4) by using stoma as a purging device. Improvement is reported only in one case, where AN symptoms improved after TNF-α therapy prescribed for CD. In contrast, severe impairment and fatal outcomes were reported for most of the patients: five patients required bowel resections, two patients developed toxic megacolon and one died as a result of occult perforation of the colon and severe cachexia. In relation to the treatment, enteral nutrition (n=4) and parenteral nutrition (n=6) were in general well tolerated. Lack of adherence to prescribed treatment was described in 6 patients. And among the 10 patients receiving corticosteroid therapy, another six of them showed concern or refusal to being treated with corticoids in relation to weight gain.
DISCUSSION
The main findings of our systematized review focused on comorbidity between IBD and ED are:
1) CD and AN are the two comorbid disorders more frequently reported; 2) epidemiologically, comorbid IBD and ED is mostly reported in young women; and 3) IBD symptoms have been reported to be used for potentiating weight loss in some cases.
Several reported papers that mention IBD and ED are focused on the misdiagnosis between CD and AN 14-21 , being the differential diagnosis sometimes difficult to establish. The first case with a comorbid diagnosis of IBD and ED was reported by Sreenivasan 35 in 1984. Since then, other authors have reported cases with ED and IBD, and several studies screening ED in patients with IBD have been published 24, 25, 27, 40, 41 , the most recent one 28 in 2016.
The scientific literature suggests that there is an association between ED and IBD, although more research is required to confirm this 24, 25, 28 . The direction of the relationship between IBD and ED also remains unclear; it is not known whether IBD leads to the development of an ED, if it is the reverse, or if the relationship is bidirectional. Wotton et al. 28 observed a significant elevated risk of being diagnosed with Ulcerative Colitis (UC), five or more years after the first admission due to AN. They also reported on a higher risk of CD in patients diagnosed with AN,
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Page 14 of 25 and vice-versa, within the first year after an admission. Similar results were described in another study 25 , where they found that the incidence and lifetime prevalence of CD were increased in patients with ED. Regardless of the direction of this link, comorbidity may lead to significant delays in diagnosis and complex therapeutic management 19, 27, 29, 30, 32, 39 . In our case, the patient showed abnormal eating behaviours since the age of 14, although the diagnosis of EDNOS was not made until she was 20. Although epidemiological studies did not report the age of the subjects, from the individual cases descriptions, it seems that this comorbidity should be especially considered in the differential diagnosis within younger patients. Additionally, the association between IBD and ED may also worsen the prognosis of both conditions 42 Regarding the role of diet in patients with IBD, Hughes et al. 11 has recently validated the Food-Related Quality of Life-29 questionnaire (FR-QoL-29). This questionnaire has been developed specifically for patients diagnosed with IBD to evaluate eating behaviours and dietary changes related with the disease and its consequences in terms of quality of life. Relative to this, some studies have suggested that these modifications in dietary patterns and gastrointestinal symptoms presented in patients with IBD may act as predisposing factors for ED 13, 24 . Some of these factors are:
-
The subjective perception of patients of some aliments triggering their IBD symptoms although scientific evidence is not enough to support this relation 11 .
Page 15 of 25 -Dietary recommendations for IBD, which often include hyperphagic diets to compensate the malabsorption due to the disease and/or short bowel syndrome after massive bowel resections 33 ; in order to avoid malnutrition and/or delayed growth in youngers 43 .
-
The need of enteral or parenteral nutrition, required for treatment in some cases, may complicate the reestablishment of food intake, as the case we presented and other one reported in the literature 31 .
-Additionally, exacerbations of postprandial abdominal pain, early satiety, anorexia or nausea have been described in patients with upper gastrointestinal CD and weight loss, which could be specially exacerbated due to the delayed gastric emptying of solids shown in AN and CD 38 .
All this may lead to food avoidance behaviours, modifying normal eating habits and increasing weight loss 13, 37, 39 .
In relation to secondary effects of treatment, Meadows and Treasure 36 were the first who proposed that changes in body shape due to corticotherapy, could explain a link between ED and IBD. The appearance of acne, moon face, oedema, and skin striae are frequent early adverse effects associated with a supra-physiological dose of corticosteroids, currently used to induce remission in CD 44 . These changes may modify the body shape of the patient and increase their weight, resulting in triggering restrictive and/or purgative behaviours to regulate it.
This theory has been supported by other authors who have described similar cases 31, 37, 38 in which patients refused prescribed corticosteroids. This time sequence, however, is not applicable to the cases where ED is the initial diagnosis 19, 29, 34, [37] [38] [39] . Other drugs used for IBD treatment, as tacrolimus, have been reported to induce anorexia nervosa-like symptoms in children 5, 45 .
In recent years, Solmi et al. 34 have offered a novelty inmuno-inflammatory hypothesis suggesting that proinflammatory cytokines (IL-6 and TNF-α), which levels are increased in CD, may be involved in the maintenance of AN symptoms . These substances and hypothalamic neuropeptides have common ways in regulating hunger/satiety and energy expenditure. Overexpression of the IL-6 may contribute to increase levels of anorexigenic peptides (proopiomelanocortin and corticotrophin-releasing hormone) and decrease orexigenic peptides
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Page 16 of 25 (neuropeptide Y, agouti-related, melanin-concentrating hormone, prepro-orexin) 46 . Additionally, IL-6 facilitates satiety by stimulating leptin sensitivity at the hypothalamus. Likewise, TNF-α promotes the effect of anorexigenic peptides in inflammatory diseases as IBD 34 . It has been also found increased levels of autoantibodies (autoAbs) against peptides related with appetite, body weight and suppression of food intake (α-melanocyte-stimulating hormone, oxytocin, vasopressin, luteinizing hormone-releasing hormone, adrenocorticotropic hormone) in patients with ED as well as in control subjects 47 . Although these autoAbs are not sufficient to cause ED 47 , it has been suggested that non-harmful autoAbs may become pathogenic and contribute to the development of ED by different mechanisms 47, 48 : 1) autoAbs may cross the blood-brain barrier and disrupt signalling at the MC4 melanocortin receptor, related with weight regulation;
2) autoAbs may also interfere with signalling on the MC3 melanocortin receptor of the arcuate nucleus, located outside the blood-brain barrier and associated with the control of food intake by substances such as neuropeptide Y (NPY); 3) autoAbs may block α-MSH function and supress the production of IL-1 and TNF-α, inhibiting food intake; and 4) autoAbs may occupy serotoninbinding sites and increase its concentration, which is a common feature found in plasma of AN patients. In this regard, several studies have described similar features for patients with IBD. It has been found that disruption in MC1 melanocortin receptor signalling may lead to worsening of colitis in mice 49 . In fact, one study showed a reduction of intestinal inflammation in murine models being treated with melanocortin-derived tripeptide α-MSH (KPV) 50 . Lower plasmatic levels of NPY have also been found in patients with IBD than in control subjects, suggesting a key role of NPY in the development of IBD by interacting with other substances as serotonin and somatostatin 51 . Likewise, serum serotonin levels may be associated and correlated with a higher pouch endoscopy inflammation in and cuffitis 52 .
Additionally, another study 53 showed lower levels of acyl ghrelin IgG autoAbs in patients with AN than in healthy subjects. In contrast, ghrelin reactive autoAbs bind mainly to des -acyl ghrelin in control subjects. In case of IBD patients, serum ghrelin levels seem to be higher in active disease than in IBD patients in remission. These elevated levels correlate with severity of the IBD and the activity markers 54 . These features suggest a possible link between gut and brain.
However, it remains unclear whether these substances play a role in the pathogenesis or maintenance of ED 34 .
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The main limitation of this review is inherent to the publication bias: there are few articles focused on this topic and they are mainly case series. Besides, it should be taken into account that frequently, published case reports are those with unusual presentations or outcomes due to their severity. At the same time, this could also support our view that less severe patients suffering this comorbidity could be underreported and/or underdiagnosed. It needs to be also highlighted that none of the publications included reported longitudinal prospective data and that only one author performed the article selection. Nevertheless, as a strength, to the authors' knowledge this is the first review addressing this comorbidity , exhaustively reviewing all published data and suggesting plausible ethiopathegenic mechanisms underlying this association. Although literature is scarce and conclusions should be taken cautiously, it is a relevant topic in daily clinical practice and its interest is growing in latest years as reflected in recent epidemiological studies 24, 25, 27, 28 .
CONCLUSION
Recent evidence suggests a possible association between IBD and ED, and some theories and risk factors have been proposed in this regard. Nevertheless, the mechanisms involved in its ethiopathogenesis are still unknown. To be aware of this condition is important because a delayed diagnosis of comorbid IBD and ED may lead to worse prognosis. Considering our experience in the management of the case described above and the cases reported by other authors, there are some clinical implications that could be of interest for clinicians. First, ED diagnosis should be considered in patients with IBD. Second, multidisciplinary approach would be recommended in these complex cases to provide an adequate therapeutic intervention.
Third, screening tools to evaluate eating attitudes and behaviours in patients with IBD could be used in daily practice, as for example the Eating Attitude Test -26 11, 55 . Further research, mostly prospective studies, is needed to firmly support this link, and to identify clinical and/or biological markers which could facilitate earlier diagnosis.
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